Abstract
The ability of insulin to stimulate glucose uptake can vary substantially in non-obese individuals with no apparent disease (10). In addition, differences in either degree of obesity or level of habitual physical activity can also modulate in vivo insulin action (18,24). In an apparent attempt to maintain glucose homeostasis, the compensatory response to a decrease in insulin-stimulated glucose up take is an increase in plasma insulin concentration. A defect in the ability of insulin-stimulated glucose uptake has also been demonstrated (21) in patients with either impaired glucose tolerance (IGT) or non-insulin dependent diabetes mellitus (NIDDM). It has been suggested that the degree to which glucose tolerance deteriorates in these individuals is a function of the level of compensatory hyperinsulinemia that they can maintain, and the appearance of severe fasting hyperglycemia marks the failure of the pancreatic beta cell to sustain the necessary increase in insulin secretory response (21).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Austin M. A (1989): Am. J. Epidemiol. 129:249–259.
Baum M. (1987): J. Clin. Invest. 79:1104–1109.
Castelli W. P. (1986): Am. Heart J. 112:432–440.
Castelli W. P., Doyle J. T., Gordon T., Hames C. G., Hjortland M. C., Hulley S. B., Kagan A. and Zukel W. J. (1977): Circulation 55:767–772.
Dall’Aglio E., Strata A. and Reaven G. M. (1988): Am J Med 84:899–903.
DeFronzo R. A., Cooke C., Andres R., Faloona G. R. and Davis P. J. (1975): J. Clin. Invest. 55:845–855.
Fuller J. H., Shipley M. J., Rose G., Jarrett R. J. and Keen H. (1980): Lancet i: 1373–1376.
Haffner S. M., Stern M. P., Mitchell B. D., Hazuda H. P. and Patterson J. K. (1990): Diabetes 39:283–288.
Harris M. I. (1989): Diabetes Care 12:464–474.
Hollenbeck G. and Reaven G. M. (1987): J. Clin. Endocrinol. Metab. 64:1169–1173.
Hwang I.-S., Ho H., Hoffman B. B. and Reaven G. M. (1987): Hypertension 10:512–516.
Laws A. and Reaven G. M. (1990): J. Int. Med. 228:415–417.
Lucas C. P., Estigarribia J. A., Darga L. L. and Reaven G. M. (1985): Hypertension 7:702–706.
MacMahon S. W., Macdonald G. J. and Blacket R. B. (1985): Arteriosclerosis 5:391–396.
McKeigue P. M., Marmot M. G., Syndercombe Court Y. D., Cottier D. E., Rahman S. and Riemersma R. A. (1988): Br. Heart J. 60:390–396.
Mondon C. E. and Reaven G. M.(1988): Metabolism 37:303–305.
Olefsky J. M., Farquhar J. W. and Reaven G. M. (1974): Am. J. Med. 57:551–560.
Olefsky J. M., Reaven G. M. and Farquhar J. W. (1974): J. Clin. Invest. 53:64–76.
Pyörälä K. (1979): Diabetes Care 2:131–141.
Reaven G. M., Lemer R. L., Stern M. P. and Farquhar J. W. (1967): J. Clin. Invest. 46: 1756–1767.
Reaven G. M. (1988): Diabetes 37:1495–1607.
Reaven G. M. and Chen Y.-D.I. (1988): Diabetes/Metab. Rev. 4:639–652.
Reaven G. M., Chang H., Hoffman B. B. and Azhar S. (1989): Diabetes 38:1155–1160.
Rosenthal M., Haskell W. L., Solomon R., Widstrom A. and Reaven G. M. (1983): Diabetes 32:408–411.
Rowe J. W., Young J. B., Minaker K. L., Stevens A. L., Pallotta J. and Landsberg L. (1981): Diabetes 30:219–225.
Saad M. F., Pettitt D. J., Mott D. M., Knowler W. C., Nelson R. G. and Bennett P. H. (1989): The Lancet 1:1356–1359.
Shieh S.-M., Shen M., Fuh M. M.-T., Chen Y.-D. I. and Reaven G. M. (1987): Atherosclerosis 67:49–55.
Tobey T. A., Greenfield M., Kraemer F. and Reaven G. M. (1981): Metabolism 30:165–171.
Welborn T.A., Breckenridge A., Rubinstein A. H., Dollery C. T. and Fraser T. R. (1966): The Lancet 1:1336–1337.
Yalow R. S. and Berson S. A. (1960): J. Clin. Invest. 39:1157–1175.
Zavaroni I., Dall’Aglio E., Alpi O., Bruschi F., Bonora E., Pezzarossa A. and Butturini U. (1985): Atherosc1erosis 55:259–266.
Zavaroni I. Bonora E., Pagliara M., Dall’Aglio E., Luchetti L., Buonanno G., Bonati P. A., Bergonzani M., Gnudi L., Passeri M. and Reaven G. M. (1989): N. Engl. J. Med. 320702–706.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Reaven, G.M. (1992). Role of Insulin Resistance in Human Disease. In: Gotto, A.M., Lenfant, C., Paoletti, R., Soma, M. (eds) Multiple Risk Factors in Cardiovascular Disease. Medical Science Symposia Series, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2700-4_10
Download citation
DOI: https://doi.org/10.1007/978-94-011-2700-4_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5196-5
Online ISBN: 978-94-011-2700-4
eBook Packages: Springer Book Archive